The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zhevago N.A.

Institut tsitologii RAN

Samoĭlova K.A.

Institut tsitologii RAN

Davydova N.I.

Vserossiĭskiĭ tsentr ékstrennoĭ i radiatsionnoĭ meditsiny im. A.M. Nikiforova MChS RF

Bychkova N.V.

Urology Clinic, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Ministry of Health of the Moscow Region, Moscow, Russia

Glazanova T.V.

Rossiĭskiĭ nauchno-issledovatel'skiĭ institut gematologii i transfuziologii FMBA Rossii

Chubukina Zh.V.

Rossiĭskiĭ NII gematologii i transfuziologii

Buynyakova A.I.

St. Petersburg Clinical Hospital of the Russian Academy of Sciences, St. Petersburg, Russia

Zimin A.A.

Research Center of Neurology, Moscow, Russia

The efficacy of polychromatic visible and infrared radiation used for the postoperative immunological rehabilitation of patients with breast cancer

Authors:

Zhevago N.A., Samoĭlova K.A., Davydova N.I., Bychkova N.V., Glazanova T.V., Chubukina Zh.V., Buynyakova A.I., Zimin A.A.

More about the authors

Journal: Problems of Balneology, Physiotherapy and Exercise Therapy. 2012;89(4): 23‑32

Views: 1105

Downloaded: 12

Download PDF (RU)
Contact the author
Table of contents

THE EFFICACY OF POLYCHROMATIC VISIBLE AND INFRARED RADIATION USED FOR THE POSTOPERATIVE IMMUNOLOGICAL REHABILITATION OF PATIENTS WITH BREAST CANCER
THE EFFICACY OF POLYCHROMATIC VISIBLE AND INFRARED RADIATION USED FOR THE POSTOPERATIVE IMMUNOLOGICAL REHABILITATION OF PATIENTS WITH BREAST CANCER

To cite this article:

Zhevago NA, Samoĭlova KA, Davydova NI, et al. . The efficacy of polychromatic visible and infrared radiation used for the postoperative immunological rehabilitation of patients with breast cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2012;89(4):23‑32. (In Russ.)

Подписка 2025-2 (Problems of Balneology, Physiotherapy and Exercise Therapy)
 
МСФ на ЯМ
Close metadata

The immunological rehabilitation of the patients with oncological problems after the completion of standard anti-tumour therapy remains a topical problem in modern medicine. The up-to-date phototherapeutic methods find the increasingly wider application for the treatment of such patients including the use of monochromatic visible (VIS) and near infrared (nIR) radiation emitted from lasers and photodiodes. The objective of the present study was to substantiate the expediency of postoperative immune rehabilitation of the patients with breast cancer (BC) by means of irradiation of the body surface with polychromatic visible (pVIS) in combination with polychromatic infrared (pIR) light similar to the natural solar radiation without its minor UV component. The study included 19 patients with stage I-II BC at the mean age of 54.0±4.28 years having the infiltrative-ductal form of the tumour who had undergone mastectomy. These patients were randomly allocated to two groups, one given the standard course of postoperative rehabilitation (control), the other (study group) additionally treated with pVIS + pIR radiation applied to the lumbar-sacral region from days 1 to 7 after surgery. A Bioptron-2 phototherapeutic device, Switzerland, was used for the purpose (480-3400 nm, 40 mW/cm2, 12 J/cm2, with the light spot diameter of 15 cm). The modern standard immunological methods were employed. It was found that mastectomy induced changes of many characteristics of cellular and humoral immunity; many of them in different patients were oppositely directed. These changes were apparent within the first 7 days postoperatively. The course of phototherapy (PT) was shown to prevent the postoperative decrease in the counts of monocytes and natural killer (NK) cells, the total amount of CD3+-T-lymphocytes (LPC), CD4+-T-helpers, activated T-lymphocytes (CD3+HLA-DR+cells) and IgA levels as well as intracellular digestion rate of neutrophil-phagocyted bacteria. Moreover PT promoted faster normalization of postoperative leukocytosis and activation of cytotoxic CD8+-T-LPC, reduced the elevated concentration of immune complexes in blood. Among the six tested cytokines, viz. IL-1Β, TNF-α, IL-6, IL-10, IFN-γ, and IFN-α, only the latter two underwent significant elevation of their blood concentrations (IL-6 within 1 day) and IFN-γ (within 7 days after mastectomy). The course of PT resulted in the decrease of their levels to the initial values. The follow-up of the treated patients during 4 years revealed neither recurrence of the disease nor the appearance of metastases.

Keywords:

breast cancer
mastectomy
immunosuppression
polychromatic (visible and infrared) light
postoperative immunological rehabilitation
phototherapy
light treatment

Authors:

Zhevago N.A.

Institut tsitologii RAN

Samoĭlova K.A.

Institut tsitologii RAN

Davydova N.I.

Vserossiĭskiĭ tsentr ékstrennoĭ i radiatsionnoĭ meditsiny im. A.M. Nikiforova MChS RF

Bychkova N.V.

Urology Clinic, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Ministry of Health of the Moscow Region, Moscow, Russia

Glazanova T.V.

Rossiĭskiĭ nauchno-issledovatel'skiĭ institut gematologii i transfuziologii FMBA Rossii

Chubukina Zh.V.

Rossiĭskiĭ NII gematologii i transfuziologii

Buynyakova A.I.

St. Petersburg Clinical Hospital of the Russian Academy of Sciences, St. Petersburg, Russia

Zimin A.A.

Research Center of Neurology, Moscow, Russia

List of references:

  1. Bazhenov S.M., Dorosevich A.E., Naperstnikov V.V. Vopr onkol 1988; 34: 9: 1041-1047.
  2. Bilynskii B.T., Loginskii V.E., Fetsich T.G. Eksper onkol 1984; 6: 3: 50-52.
  3. Gamaleya N.F., Stadnik V.Ya., Rudykh Z.M. i dr. Eksper onkol 1988; 10: 2: 60-63.
  4. Grinevich Yu.A., Alferov A.N. Lab delo 1981: 8: 493-495.
  5. Derevnina N.A., Polevaya E.B., Veskova T.K. i dr. Vopr onkol 1989; 36: 7: 810-816.
  6. Dmitrieva I.B., Bychkova N.V., Kalinina N.M. Med immunol 2003; 5: 2: 200.
  7. Zhevago N.A., Samoilova K.A., Obolenskaya K.D., Sokolov D.I. Tsitologiya 2005; 47: 5: 450-460.
  8. Ivanov A.V., Efimov O.N., Tsygankin V.I. i dr. Vopr onkol 1995; 41: 2: 141-143.
  9. Kupin V.I., Ivanov A.V., Polevaya E.B. V kn.: Deistvie nizkoenergeticheskogo lazernogo izlucheniya na krov': Tezisy konf. Kiev 1989; 116-118.
  10. Semiglazov V.F., Kondrat'ev V.B., Mar'enko A.I. Vopr onkol 1978; 8: 74-79.
  11. Tarutinov V.I., Gamaleya N.F., Sklyar S.Yu. i dr. Klin khir 1996; 1: 31-34.
  12. Totolyan A.A., Baldueva I.A., Bubnova L.N. i dr. Med immunol 1999; 1: 5: 21-43.
  13. Totolyan A.A., Freidlin I.S. Kletki immunnoi sistemy. SPb: Nauka 2001.
  14. Tyulyandin S.A., Moiseenko V.M. Prakticheskaya onkologiya: izbrannye lektsii. SPb: "Tsentr TOMM" 2004.
  15. Frimel' G., red. Immunologicheskie metody: per. s nem. M: Meditsina 1987.
  16. Khan M.A., Balabolkin I.I., Tsoi E.A. i dr. Pediatriya 2000; 2: 17-20.
  17. Baldwin D.G.R., Eng G.P., Morgan J.F. Int J Cancer 1973; 12: 1: 83-92.
  18. Bazaz M.G., Varsha C.M., Prem M. et al. Int J Cancer 1983; 20: 68-73.
  19. DeNardo D.G., Coussens L.M. Breast Cancer Research 2007; 9: 212.
  20. Fodor J. Neoplasma 1976; 23: 311-314.
  21. Hoffken K., Meredith I.D., Robins R.A. et al. Br Med J 1977; 2: 218-220.
  22. Horn Y., Hacohen D., Zeidman J.L. In: Adv. Pathol.: Anat. and Clin. Proc. 11th Trienn. World Congr. Wld Assoc Soc Pathol (Jerusalem) 1981; 1: 277-282.
  23. Iaffaioli R.V., Bianchin A., Ruggiero G. et al. Oncology 1988; 45: 337-343.
  24. Khanna S.S., Karjodkar F.R. Head Face Med 2006; 2: 33-43.
  25. Konjevic G., Spuzic I. Srp Arch Celok Lek 1995; 123: 227-231.
  26. Lucaszewic M., Mroczko B., Szmitkowski M. Pol Arch Med Wewnet 2007; 117: 1-6.
  27. Mandeville R., Lamoureux G., Legault-Polsson S., Polsson R. Cancer 1982; 50: 1280-1288.
  28. Medenica L., Lens M. J Wound Care 2003; 12: 1: 37-40.
  29. Minoru A., Hiroshi I., Tetsuo N. J Jap Soc Cancer Ther 1981; 9: 538-539.
  30. Monstrey S., Hoeksema H., Depuydt K. et al. Eur J Plast Surg 2002; 24: 377-382.
  31. Nekulova M., Tomanova J., Lang B.A. Neoplasma 1982; 29: 573-577.
  32. Nery B., Comparinu T., Ciatto S. et al. Cancer Detect Prev 1995; 8: 53-56.
  33. Parveen S., Neeraj T., Renuka J.B., Deka A.C. Indian J Dent Res 2010; 2: 10-15.
  34. Passqualini R.S., Conesa L.C., Lynch M. et al. Cell Mol Biol 1981; 27: 551-556.
  35. Samoilova K.A., Bogacheva O.N., Obolenskaya K.D. et al. Photochem Photobiol Sci 2004; 3: 1: 96-101.
  36. Samoilova K.A., Obolenskaya K.D., Vologdina A.V. et al. SPIE Proc 1998; 3569: 90-103.
  37. Zhevago N.A., Samoilova K.A., Obolenskaya K.D. et al. Photochem Photobiol Sci 2004; 3: 1: 102-108.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.